Merck & Co., Inc. (MRK)
96.92
-2.00
(-2.03%)
USD |
NYSE |
Dec 09, 16:00
96.99
+0.06
(+0.07%)
After-Hours: 19:37
Merck Total Liabilities (Quarterly): 77.64B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen, Inc. | 80.52B |
| Biogen, Inc. | 11.00B |
| Regeneron Pharmaceuticals, Inc. | 9.212B |
| Cidara Therapeutics, Inc. | 96.26M |
| Moderna, Inc. | 2.805B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 129.55B |
| Shareholders Equity (Quarterly) | 51.85B |
| Debt to Equity Ratio | 0.798 |
| Current Ratio | 1.661 |
| Net Debt Paydown Yield | -0.34% |